Marc Beer holds over two decades of experience in the biotechnology industry, during which time he has worked with a variety of organizations. Throughout this time, he has seen a considerable amount of success and has brought many of the firms that he worked with to the top of their respective niches. The most prominent reason behind this is that the entrepreneur has consistently looked for unique and creative solutions to the challenges that these companies face, as well as helping to grow their market share considerably.
Before entering the industry, Beer started developing his skills at Miami University, which he eventually graduated from in 1987 with a Bachelor of Science in Business. Following this, he began working in pharmaceutical sales and marketing, during which time he served with a variety of firms. One of the most notable of these during his early career was Genzyme, in which he soon began working his way up. Eventually, this led to the entrepreneur being named the firm’s Vice President of Global Marketing.
As a result of this, he was able to help the company’s product line to the 350 million potential customers that these products could benefit from. While with Genzyme, Marc Beer developed an interest in creating his firm. Armed with the skills and knowledge that he had obtained over the previous years, he decided to take the risk and left the company, eventually going on to found ViaCell. In the years following this, the pharmaceutical sales and marketing organization would go on to see a significant amount of success.
After being founded in 2000, the company would go on to be listed on the NASDAQ, as well as work on a large number of projects. In 2007, this led to the firm being sold to PerkinElmer for $300 million. However, it was soon after Marc Beer saw this success that tragedy struck, as his wife died suddenly as a result of a pulmonary embolism. This led to the entrepreneur taking an extended break from his career to look after his three children. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
After a few short years, however, one of his daughters told him that he should focus back on his entrepreneurial pursuits. As a result of this, he soon saw himself becoming involved in a variety of organizations, the majority of which would see a significant amount of success. In was in 2016, however, that Marc Beer would receive an opportunity that would be too good to miss up. This began when he received a phone call from Dr. Ray Iglesias, a gynecologist with over three decades of experience treating pelvic floor disorders.
In the months that would follow, the pair would create a company that would end up being called Renovia, which has seen a large amount of success since being founded. Throughout the following two years, the company would go through a variety of research and development phases, with Marc Beer eventually leading the company to release the Leva device, which received approval from the Food and Drug Administration (FDA) in April 2018.